Prof Ibrahim Abubakar
Dean, Faculty of Population Health Sciences
Faculty of Pop Health Sciences
School of Life & Medical Sciences
- Joined UCL
- 20th Sep 2010
Prof Abubakar runs a global health research programme that addresses major diseases affecting vulnerable groups. His work focuses on the epidemiology, prevention and treatment of infections including tuberculosis, hepatitides, HIV, and emerging infections particularly among underserved populations.
Supervises PhD students in infectious disease epidemiology and migration and health. Teaches on the global health and applied infectious disease epidemiology MScs.
- Royal College of Physicians
- Doctorate, Fellow of the Royal College of Physicians | 2012
- University of East Anglia
- Doctorate, Doctor of Philosophy | 2007
- University of Cambridge
- First Degree, Diplom | 2001
- London School of Hygiene and Tropical Medicine
- Other higher degree, Master of Science | 1999
- Ahmadu Bello University
- Doctorate, Bachelor of Medicine/Bachelor of Surgery | 1992
Ibrahim Abubakar is Dean, UCL Faculty of Population Health Sciences and Professor of Infectious Disease Epidemiology. He was director of the UCL Institute for Global Health until July 2021. He was appointed NIHR Senior Investigator in 2017 and elected Fellow Academy of Medical Sciences in 2020. He led the UCL Centre for Infectious Disease Epidemiology, UCL-TB and was a senior investigator at the MRC Clinical Trials Unit. He was head of TB at Public Health England. Prior to his appointment at UCL, he was Professor in Health Protection at the Norwich Medical School.
He qualified in medicine in 1992 and initially trained in general medicine before specialising in public health medicine. His academic public health training was undertaken at LSHTM, University of Cambridge and the University of East Anglia.
He is a member of the Global Preparedness Monitoring Board. He is the chair of Lancet Migration: global collaboration to advance migration health, Lancet Nigeria Commission and the NIHR Global Health Professorship Committee. He served as chair of the WHO Strategic and Technical Advisory Group for Tuberculosis until 2019 and of the Wellcome Trust Expert Review Group on Population Health until 2022.